Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study.

Autor: Arrestier, Romain1,2,3 (AUTHOR), Bastard, Paul4,5,6 (AUTHOR), Belmondo, Thibaut7 (AUTHOR), Voiriot, Guillaume8 (AUTHOR), Urbina, Tomas9 (AUTHOR), Luyt, Charles-Edouard10,11 (AUTHOR), Gervais, Adrian4,5,6 (AUTHOR), Bizien, Lucy4,5,6 (AUTHOR), Segaux, Lauriane3,12 (AUTHOR), Ben Ahmed, Mariem5 (AUTHOR), Bellaïche, Raphaël13 (AUTHOR), Pham, Taï14 (AUTHOR), Ait-Hamou, Zakaria15 (AUTHOR), Roux, Damien16 (AUTHOR), Clere-Jehl, Raphael17 (AUTHOR), Azoulay, Elie17 (AUTHOR), Gaudry, Stéphane18 (AUTHOR), Mayaux, Julien19 (AUTHOR), Fage, Nicolas14 (AUTHOR), Ait-Oufella, Hafid9 (AUTHOR)
Zdroj: Annals of Intensive Care. 12/31/2022, Vol. 12 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje